Alogliptin/Pioglitazone (Liovel) Liovel Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus
The purpose of this study is to examine the safety and efficacy of long-term use of
alogliptin/pioglitazone(Liovel) combination tablets in patients with type 2 diabetes
mellitus determined as warranting combination therapy with alogliptin benzoate and
This study will evaluate the efficacy and safety of alogliptin 25 mg once daily (QD)
compared to placebo when administered as monotherapy, or when added onto a background of
metformin alone, insulin alone, or a combination of metformin and insulin in pediatric
participants 10 to 17 years of age with type 2 diabetes mellitus (T2DM).
A Study to Evaluate the Effect of add-on Pioglitazone or Glimepiride in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy
Not yet recruiting
The purpose of this study is to compare the efficacy of pioglitazone plus alogliptin plus
metformin with glimepiride plus alogliptin plus metformin on glycosylated haemoglobin (HbA1c)
change from baseline to Week 26.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.